Expected Drop In COVID-19 Vaccine Sales Hits Beximco’s Bottom Line

Subsidiary Entities Collectively Profitable For First Time Following Synovia Acquisition

 
• By Chloe Kent
Vector of a COVID-19 vaccine vial on top of a graph displaying a downward trajectory
Beximco's income stream from COVID-19 vaccines has now dried up • Source: Shutterstock

More from Earnings

More from Business